Intensive initial therapy with triple DMARDs improves functional ability in early RA
The results of the tREACH trial presented today at the European League Against Rheumatism Annual Congress (EULAR 2015) Press Conference showed that initial therapy with combination DMARDs significantly improves measures of ...
Jun 10, 2015
0
5